As of September 2024 BrightPath Biotherapeutics has 59.66M shares outstanding, a increase of 14.75% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 59.66M | 14.75% |
2022 | 51.99M | 9.27% |
2021 | 47.58M | 13.20% |
2020 | 42.03M | - |